The Cyprus Institute of Neurology & Genetics (CING) is a private, non-profit, bi-communal, medical, research and academic center.
CING commenced operations in 1990 at the Makarios III Hospital in Nicosia and in 1995, CING moved to its own purpose-built premises. Due to the need in Cyprus to provide high level laboratory and clinical services, the Cyprus Government funded CING annually, in return for the provision of high level clinical and diagnostic services to Government Hospitals.
Since 1995, CING has been providing high level services and the most competitive and innovative biomedical research aiming towards early detection and prevention of disease. Moreover, it provides postgraduate education which is closely associated to research and service activities.
CING serves the needs of patients, society and the country as a whole, as its activities directly relate to and reflect the needs of Cyprus and its citizens.
CING is dedicated to lessening the suffering of patients and their families and preventing diseases through patient care, research and educational programs on neurological and genetic conditions such as muscular dystrophy, multiple sclerosis, epilepsy, chromosomal abnormalities and all other aspects of molecular biology and genetics such as thalassaemia, molecular virology, mental retardation, cardiovascular disease, stroke, cystic fibrosis and neurogenetics. Moreover, CING plays a key role in the fight against crime by providing specialized DNA services to the police authorities and expert court testimony for criminal and civil investigations.
CING is a medical and biomedical translation center, which is probably the most successful model nowadays as it combines education, service and research activities in one center, providing major medical benefits to the people, society and the country. CING was one of the first, and today one of the best, examples in Europe where postgraduate education, research and service have been successfully combined.
CING receives international recognition and plays an active and essential role as a national, regional and international center of excellence for the provision of high quality services, innovative research and postgraduate education.
In 2012, CING also established the Cyprus School of Molecular Medicine (CSMM), a postgraduate school with research and academic interests relevant to CING activities. CSMM offers seven programs of study leading to MSc and PhD degrees in the fields of Molecular Medicine, Medical Genetics, Neuroscience and Biomedical Research.
For more information please visit CING website.
Participating Entities and Major Infrastructure
The CING has the largest and most technologically developed infrastructure in Cyprus in the sectors of Neurology, Genetics and Biomedical Sciences and has been organized and staffed according to European and International standards. CING is housed in its own purpose-built premises made up of an area of 10,000 m² and it includes adequate laboratory and office space for the purposes of this study. The facility is approved and funded by the Cyprus Government.